106 related articles for article (PubMed ID: 31332656)
21. Intranasal immunization with heat shock protein 60 induces CD4(+) CD25(+) GARP(+) and type 1 regulatory T cells and inhibits early atherosclerosis.
Zhong Y; Tang H; Wang X; Zeng Q; Liu Y; Zhao XI; Yu K; Shi H; Zhu R; Mao X
Clin Exp Immunol; 2016 Mar; 183(3):452-68. PubMed ID: 26452441
[TBL] [Abstract][Full Text] [Related]
22. B cells treated with CTB-p210 acquire a regulatory phenotype in vitro and reduce atherosclerosis in apolipoprotein E deficient mice.
Rattik S; Mantani PT; Yao Mattisson I; Ljungcrantz I; Sundius L; Björkbacka H; Terrinoni M; Lebens M; Holmgren J; Nilsson J; Wigren M; Nordin Fredrikson G
Vascul Pharmacol; 2018 Dec; 111():54-61. PubMed ID: 30243560
[TBL] [Abstract][Full Text] [Related]
23. Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice.
Maron R; Sukhova G; Faria AM; Hoffmann E; Mach F; Libby P; Weiner HL
Circulation; 2002 Sep; 106(13):1708-15. PubMed ID: 12270867
[TBL] [Abstract][Full Text] [Related]
24. Establishment of nasal tolerance to heat shock protein-60 alleviates atherosclerosis by inducing TGF-β-dependent regulatory T cells.
Li H; Ding Y; Yi G; Zeng Q; Yang W
J Huazhong Univ Sci Technolog Med Sci; 2012 Feb; 32(1):24-30. PubMed ID: 22282240
[TBL] [Abstract][Full Text] [Related]
25. Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of Atherosclerosis.
Rahtu-Korpela L; Määttä J; Dimova EY; Hörkkö S; Gylling H; Walkinshaw G; Hakkola J; Kivirikko KI; Myllyharju J; Serpi R; Koivunen P
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):608-17. PubMed ID: 26848160
[TBL] [Abstract][Full Text] [Related]
26. Regulatory T-cell response to apolipoprotein B100-derived peptides reduces the development and progression of atherosclerosis in mice.
Herbin O; Ait-Oufella H; Yu W; Fredrikson GN; Aubier B; Perez N; Barateau V; Nilsson J; Tedgui A; Mallat Z
Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):605-12. PubMed ID: 22223728
[TBL] [Abstract][Full Text] [Related]
27. Combination therapy with cilostazol and pravastatin improves antiatherogenic effects in low-density lipoprotein receptor knockout mice.
Park KY; Heo TH
Cardiovasc Ther; 2018 Dec; 36(6):e12476. PubMed ID: 30378752
[TBL] [Abstract][Full Text] [Related]
28. Induction of T helper 2 responses against human apolipoprotein B100 does not affect atherosclerosis in ApoE-/- mice.
Engelbertsen D; Rattik S; Knutsson A; Björkbacka H; Bengtsson E; Nilsson J
Cardiovasc Res; 2014 Jul; 103(2):304-12. PubMed ID: 24866382
[TBL] [Abstract][Full Text] [Related]
29. The intravenous injection of oxidized LDL- or Apolipoprotein B100--Coupled splenocytes promotes Th1 polarization in wildtype and Apolipoprotein E--Deficient mice.
Steinmetz M; Ponnuswamy P; Laurans L; Esposito B; Tedgui A; Mallat Z
Biochem Biophys Res Commun; 2015 Aug; 464(1):306-11. PubMed ID: 26116775
[TBL] [Abstract][Full Text] [Related]
30. Oxidized low-density lipoprotein-induced apoptotic dendritic cells as a novel therapy for atherosclerosis.
Frodermann V; van Puijvelde GH; Wierts L; Lagraauw HM; Foks AC; van Santbrink PJ; Bot I; Kuiper J; de Jager SC
J Immunol; 2015 Mar; 194(5):2208-18. PubMed ID: 25653425
[TBL] [Abstract][Full Text] [Related]
31. Immunization of Chlamydia pneumoniae (Cpn)-infected Apob(tm2Sgy)Ldlr(tm1Her)/J mice with a combined peptide of Cpn significantly reduces atherosclerotic lesion development.
Xia M; Chen D; Endresz V; Faludi I; Szabo A; Gonczol E; Kakkar V; Lu X
PLoS One; 2013; 8(12):e81056. PubMed ID: 24349031
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological activation of the melanocortin system limits plaque inflammation and ameliorates vascular dysfunction in atherosclerotic mice.
Rinne P; Silvola JM; Hellberg S; Ståhle M; Liljenbäck H; Salomäki H; Koskinen E; Nuutinen S; Saukko P; Knuuti J; Saraste A; Roivainen A; Savontaus E
Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1346-54. PubMed ID: 24790139
[TBL] [Abstract][Full Text] [Related]
33. Treatment with apo B peptide vaccines inhibits atherosclerosis in human apo B-100 transgenic mice without inducing an increase in peptide-specific antibodies.
Fredrikson GN; Björkbacka H; Söderberg I; Ljungcrantz I; Nilsson J
J Intern Med; 2008 Dec; 264(6):563-70. PubMed ID: 18783480
[TBL] [Abstract][Full Text] [Related]
34. Regression of atherosclerosis with therapeutic antibodies pipe cleaner or pipe dream?
Ginsburg GS
J Am Coll Cardiol; 2007 Dec; 50(24):2319-21. PubMed ID: 18068041
[No Abstract] [Full Text] [Related]
35. Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis.
van Puijvelde GH; Hauer AD; de Vos P; van den Heuvel R; van Herwijnen MJ; van der Zee R; van Eden W; van Berkel TJ; Kuiper J
Circulation; 2006 Oct; 114(18):1968-76. PubMed ID: 17060383
[TBL] [Abstract][Full Text] [Related]
36. Mycobacterial heat shock protein 65 (mbHSP65)-induced atherosclerosis: Preventive oral tolerization and definition of atheroprotective and atherogenic mbHSP65 peptides.
Grundtman C; Jakic B; Buszko M; Onestingel E; Almanzar G; Demetz E; Dietrich H; Cappellano G; Wick G
Atherosclerosis; 2015 Sep; 242(1):303-10. PubMed ID: 26233917
[TBL] [Abstract][Full Text] [Related]
37. Oxidized Low-Density Lipoprotein Receptor in Lymphocytes Prevents Atherosclerosis and Predicts Subclinical Disease.
Tsilingiri K; de la Fuente H; Relaño M; Sánchez-Díaz R; Rodríguez C; Crespo J; Sánchez-Cabo F; Dopazo A; Alonso-Lebrero JL; Vara A; Vázquez J; Casasnovas JM; Alfonso F; Ibáñez B; Fuster V; Martínez-González J; Martín P; Sánchez-Madrid F
Circulation; 2019 Jan; 139(2):243-255. PubMed ID: 30586697
[TBL] [Abstract][Full Text] [Related]
38. Oral FTY720 administration induces immune tolerance and inhibits early development of atherosclerosis in apolipoprotein E-deficient mice.
Huang K; Li SQ; Wang WJ; Liu LS; Jiang YG; Feng PN; Wang YQ; Wang SM
Int J Immunopathol Pharmacol; 2012; 25(2):397-406. PubMed ID: 22697071
[TBL] [Abstract][Full Text] [Related]
39. Vaccination to modulate atherosclerosis.
Kimura T; Tse K; Sette A; Ley K
Autoimmunity; 2015 May; 48(3):152-60. PubMed ID: 25683179
[TBL] [Abstract][Full Text] [Related]
40. Autoimmune responses against the apo B-100 LDL receptor-binding site protect against arterial accumulation of lipids in LDL receptor deficient mice.
Fredrikson GN; Lindholm MW; Ljungcrantz I; Söderberg I; Shah PK; Nilsson J
Autoimmunity; 2007 Mar; 40(2):122-30. PubMed ID: 17453711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
